top of page
Oral Biologics Platform
Powered by BioPYM
Search
All Posts


Fzata is Developing a New Hope in the Fight Against C. diff
April 9, 2026 C. diff (short for Clostridioides difficile ) is a serious infection that affects the gut. It can cause intense diarrhea, painful cramping, and extreme fatigue—sometimes lasting for weeks. For many patients, it’s not just uncomfortable; it can completely disrupt daily life. Some people recover after treatment and return to normal. But for many others, the infection comes back. In fact, about 1 in 3 patients will experience a recurrence after their first infecti
elizabethsmith74
Apr 92 min read


What It Means to Build an Emerging Life Sciences Company Today
April 1, 2026 Fzata being named a finalist for the Maryland ICON Award for Emerging Life Sciences Company of the Year is an honor. We are grateful to Maryland Tech Council and Maryland’s life sciences community which have long supported early innovation through funding, infrastructure, and talent. For companies like Fzata, that support is part of what makes it possible to reach this stage with a first-in-class platform and a defined path forward. This is a perfect moment to r
elizabethsmith74
Apr 12 min read


On World IBD Day, Fzata Stands with the IBD Community — And Looks to the Future with FZ006
May 19, 2025 On May 19, millions come together to recognize World IBD Day, a time to raise awareness and support for those living with...
elizabethsmith74
May 19, 20253 min read
bottom of page
